ロード中...
Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine
One year after the first human case of SARS-CoV-2, two nanomedicine-based mRNA vaccines have been fast-tracked, developed, and have received emergency use authorization throughout the globe with more vaccine approvals on the heels of these first two. Several SARS-CoV-2 vaccine compositions use nanot...
保存先:
| 出版年: | Drug Deliv Transl Res |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7845267/ https://ncbi.nlm.nih.gov/pubmed/33512669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13346-021-00911-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|